Literature DB >> 21468128

Hematology: relapsed and refractory PTCL--into the therapeutic abyss.

Francine Foss.   

Abstract

Mesh：

Substances：

Year:  2011        PMID： 21468128     DOI： 10.1038/nrclinonc.2011.51

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN： 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  7 in total

1.  The results of consolidation with autologous stem-cell transplantation in patients with peripheral T-cell lymphoma (PTCL) in first complete remission: the Spanish Lymphoma and Autologous Transplantation Group experience.

Authors:  J Rodríguez; E Conde; A Gutiérrez; R Arranz; A León; J Marín; M Bendandi; C Albo; M D Caballero
Journal:  Ann Oncol       Date:  2007-01-17       Impact factor: 32.976

2.  Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma.

Authors:  Richard L Piekarz; Robin Frye; H Miles Prince; Mark H Kirschbaum; Jasmine Zain; Steven L Allen; Elaine S Jaffe; Alexander Ling; Maria Turner; Cody J Peer; William D Figg; Seth M Steinberg; Sonali Smith; David Joske; Ian Lewis; Laura Hutchins; Michael Craig; A Tito Fojo; John J Wright; Susan E Bates
Journal:  Blood       Date:  2011-02-25       Impact factor: 22.113

3.  Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.

Authors:  Owen A O'Connor; Barbara Pro; Lauren Pinter-Brown; Nancy Bartlett; Leslie Popplewell; Bertrand Coiffier; Mary Jo Lechowicz; Kerry J Savage; Andrei R Shustov; Christian Gisselbrecht; Eric Jacobsen; Pier Luigi Zinzani; Richard Furman; Andre Goy; Corinne Haioun; Michael Crump; Jasmine M Zain; Eric Hsi; Adam Boyd; Steven Horwitz
Journal:  J Clin Oncol       Date:  2011-01-18       Impact factor: 44.544

4.  Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.

Authors:  Norbert Schmitz; Lorenz Trümper; Marita Ziepert; Maike Nickelsen; Anthony D Ho; Bernd Metzner; Norma Peter; Markus Loeffler; Andreas Rosenwald; Michael Pfreundschuh
Journal:  Blood       Date:  2010-07-21       Impact factor: 22.113

5.  International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes.

Authors:  Julie Vose; James Armitage; Dennis Weisenburger
Journal:  J Clin Oncol       Date:  2008-07-14       Impact factor: 44.544

6.  Phase II-I-II study of two different doses and schedules of pralatrexate, a high-affinity substrate for the reduced folate carrier, in patients with relapsed or refractory lymphoma reveals marked activity in T-cell malignancies.

Authors:  Owen A O'Connor; Steven Horwitz; Paul Hamlin; Carol Portlock; Craig H Moskowitz; Debra Sarasohn; Ellen Neylon; Jill Mastrella; Rachel Hamelers; Barbara Macgregor-Cortelli; Molly Patterson; Venkatraman E Seshan; Frank Sirotnak; Martin Fleisher; Diane R Mould; Mike Saunders; Andrew D Zelenetz
Journal:  J Clin Oncol       Date:  2009-08-03       Impact factor: 44.544

7.  Autologous stem-cell transplantation as first-line therapy in peripheral T-cell lymphomas: results of a prospective multicenter study.

Authors:  Peter Reimer; Thomas Rüdiger; Eva Geissinger; Florian Weissinger; Christoph Nerl; Norbert Schmitz; Andreas Engert; Hermann Einsele; Hans Konrad Müller-Hermelink; Martin Wilhelm
Journal:  J Clin Oncol       Date:  2008-11-24       Impact factor: 44.544
  7 in total
  4 in total

Review 1.  Recent Advances in the Treatment of Peripheral T-Cell Lymphoma.

Authors:  Kamel Laribi; Mustapha Alani; Catherine Truong; Alix Baugier de Materre
Journal:  Oncologist       Date:  2018-04-19

Review 2.  Highly Diverse Efficacy of Salvage Treatment Regimens for Relapsed or Refractory Peripheral T-Cell Lymphoma: A Systematic Review.

Authors:  Ya-Ting Yang; Cheng-Jeng Tai; Chiehfeng Chen; Hong-Cheng Wu; Natalia Mikhaylichenko; Hsien-Tsai Chiu; Yun-Yi Chen; Yi-Hsin Elsa Hsu
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

Review 3.  Therapeutic options in peripheral T cell lymphoma.

Authors:  Yaping Zhang; Wei Xu; Hong Liu; Jianyong Li
Journal:  J Hematol Oncol       Date:  2016-04-12       Impact factor: 17.388

4.  Outcome and Prospective Factor Analysis of High-dose Therapy Combined with Autologous Peripheral Blood Stem Cell Transplantation in Patients with Peripheral T-cell Lymphomas.

Authors:  Meng Wu; Xiaopei Wang; Yan Xie; Weiping Liu; Chen Zhang; Lingyan Ping; Zhitao Ying; Lijuan Deng; Wen Zheng; Ningjing Lin; Meifeng Tu; Yuqin Song; Jun Zhu
Journal:  Int J Med Sci       Date:  2018-06-04       Impact factor: 3.738
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.